Genetic evidence for the involvement of τ in progressive supranuclear palsy

Annals of Neurology

Volumn 41, Issue 2, 1997, Pages 277-281

  Conrad, Chris ^a   Andreadis, Athena ^b   Trojanowski, John Q ^c   Dickson, Dennis W ^d   Kang, David ^a   Chen, Xiaohua ^a   Wiederholt, Wigbert ^a   Hansen, Larry ^a   Masliah, Eliezer ^a   Thal, Leon J ^a   Katzman, Robert ^a   Xia, Yu ^a   Saitoh, Tsunao ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; INTRON; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

BASE SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0031044850     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410222     Document Type: Article

References (24)

1. Kosik KS, Tau protein and neurodegeneration. Mol Neurobiol 1990;4:171-179
2. Trojanowski JQ, Clark CM, Schmidt ML, et al. Implication of tau-rich neurofibrillary lesions for the pathobiology and diagnosis of Alzheimer's disease. In: Appel YB, ed. Current neurology, vol 16. Boston: Houghton-Mifflin, 1996 (In press)
3. Kato T, Hirano A, Katagiri T, et al. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann Neurol 1988;23:620-623
4. Drewes G, Trinczek B, Illenberger S, et al. Microtubule-associated protein/microtubule affinity-regulating kinase (p110 mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262. J Biol Chem 1995;270: 7679-7688
5. Mandelkow EM, Biernat J, Drewes G, et al. Microtubule-associated protein tau, paired helical filaments, and phosphorylation. Ann NY Acad Sci 1993;695:209-216
6. Schweers O, Mandelkow E, Biernat J, Mandelkow E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc Natl Acad Sci USA 1995;92:8463-8467
7. Xia Y, de Silva H, Rosi B, et al. Genetic association of an NACP/(-synuclein polymorphism with Alzheimer's disease. Ann Neurol 1996;40:207-215
8. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019
9. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173
10. Gearing M, Oison D, Watts R, Mirra S. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024
11. Chen X, Xia Y, Gresham L, et al. APOE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, Guam. Neurology 1996;47:779-784
12. Andreadis A, Brown W, Kosik K. Structure and novel exons of the human tau gene. Biochemistry 1992;31:10626-10633
13. Feener CA, Boyce FM, Kunkel LM. Rapid detection of CA polymorphisms in cloned DNA: application to the 5′ region of the dystrophin gene. Am J Hum Genet 1991;48:621-627
14. Golbe L, Davis P, Schoenberg B, Duvoisin R. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;28:1031-1034
15. Jackson J, Jankovic J, Ford J. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 1983;13:273-278
16. Love S, Saitoh T, Quijada S, et al. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 1988;47:393-405
17. Schmidt ML, Huang R, Martin JA, et al. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHF-tau. J Neuropathol Exp Neurol 1996;55:534-539
18. Baum L, Masliah E, Iimoto DS, et al. Casein kinase II is associated with neurofibrillary tangles bur is not an intrinsic component of paired helical filaments. Brain Res 1992;573:126-132
19. Jellinger K, Bancher C. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy, clinical and research approaches. New York: Oxford University Press, 1992:44-88
20. Schmidt M, Lee V, Hurtig H, Trojanowski J. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Lab Invest 1988;59:460-466
21. Flament S, Delacourte A, Verny M, et al. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol 1991;81:591-596
22. de Yebenes JG, Sarasa JL, Daniel SE, Lees AJ. Familial progressive supranuclear palsy. Description of a pedigree and review of the literature. Brain 1995;118:1095-1103
23. Kerem B-S, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245: 1073-1080
24. Baum L, Seger R, Woodgett R, et al. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: implication of phosphoprotein phosphatase involvement. Mol Brain Res 1995;34:1-17